Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 27, 2026
Why Is Boost Run (BRUN) Stock Down -13.75% Today?

Why Is Boost Run (BRUN) Stock Down -13.75% Today?

Key Takeaways

  • BRUN shares plunged 13.75% to $18.75 on Monday, extending a brutal July sell-off that has now erased more than half the stock's value from its recent peak.
  • The primary catalyst was the company's announcement of a mandatory warrant redemption, which reignited fears of substantial shareholder dilution as remaining warrants are either exercised or extinguished.
  • A previously filed secondary offering registration covering up to 58.74 million shares continues to cast a long shadow over the stock, compounding dilution anxiety.
  • Broader weakness across high-growth AI and software names — driven by lingering interest rate uncertainty — is amplifying the downside pressure on speculative cloud infrastructure plays.
  • Traders are now watching whether the stock can stabilize near its 200-day moving average around the $16.87 level, or if the selling cascade will carry shares toward the 52-week low.

Opening Summary

Boost Run, Inc. (BRUN), an NVIDIA Preferred Cloud Provider that builds GPU-accelerated infrastructure for enterprise AI and high-performance computing workloads, saw its stock crater 13.75% in Monday's session. Shares tumbled to $18.75, down sharply from Friday's closing price of $21.74, as investors reacted to the company's formal warrant redemption notice and the persistent overhang of a massive registered secondary offering. The decline extends a punishing multi-week drawdown that has seen the stock lose roughly 55% from its 52-week high of $42.00, marking one of the most severe corrections among publicly traded AI infrastructure names in 2026.

Warrant Redemption Announcement Fuels Dilution Alarm

The immediate trigger for Monday's plunge was Boost Run's announcement that it will redeem all outstanding public warrants at just $0.01 apiece, effective August 20, 2026. Holders now face a binary choice: exercise their warrants at $11.50 per share before the deadline, or watch them become virtually worthless. Each warrant exercised converts into one share of Class A common stock, meaning full exercise of the remaining 55% of outstanding warrants would inject another $73.1 million in gross cash proceeds — but also flood the market with millions of additional shares. While the company framed the move as a balance-sheet strengthening exercise, having already collected $58.8 million from warrants exercised to date, the market quickly priced in the dilutive impact of potentially tens of millions of new shares hitting the float.

Secondary Offering Overhang Compounds Selling Pressure

The warrant redemption did not arrive in a vacuum. Earlier in July, Boost Run filed a registration statement covering the potential resale of up to 58.74 million shares of Class A common stock by existing holders. That filing — combined with the roughly 4 million shares already issued through recent warrant exercises — has created a persistent supply overhang that has weighed on the stock throughout the month. With fresh warrant-driven issuance now layered on top, investors are recalibrating the per-share value of their holdings against a meaningfully larger denominator. The market's sensitivity to dilution risk in post-SPAC structures has been especially acute in 2026, and BRUN is now the poster child for that anxiety.

Broader Tech and Macro Headwinds

Boost Run's sell-off is also unfolding against a challenging macro backdrop. The Federal Reserve's recent signals around possible additional rate hikes have soured sentiment toward high-growth, pre-profit technology names that depend on cheap capital to fund aggressive expansion. AI cloud infrastructure stocks, which surged earlier in the year on enthusiasm around enterprise adoption, have faced a sharp reversal in recent weeks as traders reassess the timeline for converting ambitious deployment targets into actual revenue. With Boost Run still generating operating losses — posting negative operating income of $3.3 million in its most recent quarter — the rate-sensitive, execution-dependent nature of the business leaves it particularly vulnerable when risk appetite contracts.

Market Context and Trading Activity

Volume in BRUN surged well above its daily average, signaling institutional repositioning rather than retail noise. The stock sliced through multiple technical support levels during the session, including the psychologically important $20.00 threshold, and is now trading firmly below both its 30-day and 50-day moving averages. The move diverged notably from the broader Nasdaq Composite, which held relatively steady, confirming that the selling is driven by company-specific rather than purely macro forces. The stock's 200-day moving average near $16.87 now stands as the next major support zone that traders are closely monitoring. With a 52-week low of $10.25 and a 52-week high of $42.00, the current price of $18.75 sits uncomfortably in the lower quartile of that range.

What Comes Next for BRUN

The coming weeks will be pivotal for Boost Run. The August 20 warrant redemption deadline creates a hard catalyst date — the pace of warrant exercises between now and then will determine how much additional dilution materializes. Beyond that, investors will be scrutinizing the company's next earnings report, expected around the end of August, for evidence that its headline-grabbing customer contracts — including the $471.7 million Thinking Machines deal and the $127 million Fluidstack agreement — are translating into deployed capacity and recognized revenue. Management's raised GPU deployment target of $250 million for 2026 is ambitious, and any sign of slippage against that goal could trigger another leg lower. On the flip side, if deployment milestones are met and customer billing ramps as planned, the current sell-off may eventually be viewed as a painful but temporary overreaction to capital-structure noise. For now, the balance of risks leans heavily toward execution delivery.

Trending AI Robots

For traders seeking to navigate volatile markets with data-driven precision, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to adapt to shifting market conditions. Tickeron maintains hundreds of AI trading bots covering thousands of tickers across diverse strategies and timeframes, but only those demonstrating the strongest real-time performance under current market dynamics are featured in this rotating showcase. Each bot varies by strategy type, performance metrics, traded symbols, and risk profile, giving users a window into which algorithmic approaches are thriving right now. Explore the Trending AI Robots page to discover which AI-driven strategies are currently leading the pack.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BRUN

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


BRUN's RSI Indicator climbs out of oversold territory

The RSI Oscillator for BRUN moved out of oversold territory on July 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 3 similar instances when the indicator left oversold territory. In of the 3 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 14 cases where BRUN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 11, 2026. You may want to consider a long position or call options on BRUN as a result. In of 22 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BRUN just turned positive on August 11, 2026. Looking at past instances where BRUN's MACD turned positive, the stock continued to rise in of 12 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BRUN advanced for three days, in of 73 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRUN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BRUN entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BRUN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BRUN's P/B Ratio (322.581) is very high in comparison to the industry average of (24.057). P/E Ratio (0.000) is within average values for comparable stocks, (74.273). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.911). BRUN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.021). P/S Ratio (32.051) is also within normal values, averaging (134.061).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRUN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), NetApp (NASDAQ:NTAP), Twilio (NYSE:TWLO), MongoDB (NASDAQ:MDB), Zscaler (NASDAQ:ZS), Okta (NASDAQ:OKTA).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 35.26B. The market cap for tickers in the group ranges from 48.8K to 3.66T. MSFT holds the highest valuation in this group at 3.66T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was 2%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 25%. AIFA experienced the highest price growth at 94%, while GYGY experienced the biggest fall at -40%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -28%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -65%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 72
Price Growth Rating: 56
SMR Rating: 80
Profit Risk Rating: 91
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
BRUN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry ComputerCommunications

Profile
Details
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Why Is Boost Run (BRUN) Stock Down -13.75% Today?